COVID‑19 and MERS: Are their Chest X‑ray and Computed Tomography Scanning Signs Related?

COVID‑19 is a respiratory infection brought about by SARS‑COV‑2. Most of the patients contaminated by this pathogen are afflicted by respiratory syndrome with multiple stages ranging from mild upper respiratory involvement to severe dyspnea and acute respiratory distress syndrome cases. Keeping in mind the high sensitivity of computed tomography (CT) scan in detecting abnormalities, it became the number one modality in COVID‑19 diagnosis. A wide diversity of CT features can be found in COVID‑19 cases, which can be observed before the onset of clinical signs. The review article is aimed to highlight recent discrepancies in CT‑scan and chest X‑ray (CXR) characteristics between COVID‑19 and Middle East Respiratory Syndrome (MERS).

This review study was performed in the literature from the beginning of COVID‑19 until the middle of April 2021. For this reason, all relevant works through scientific citation websites such as Google Scholar, PubMed, and Web of Science have been investigated in the mentioned period.

COVID‑19 was more reproductive than MERS, while MERS was significantly higher in terms of mortality rate (COVID‑19: 2.3% and MERS: 34.4%). Signs of ground‑glass opacity (GGO), peripheral consolidation, and GGO accompanying with consolidation are the same signs CXR in both MERS and COVID‑19. Indeed, fever, cough, headache, and sore throat are the most symptoms in all studied patients.

Both COVID‑19 and MERS have the same imaging signs. The most similar chest CT findings are GGO, peripheral consolidation, and GGO superimposed by consolidation in both studied diseases, and no statistical differences were seen among the mean number of chest CT‑scans in MERS and COVID‑19 cases.